Specific membrane receptors for human interferon-gamma (IFN-gamma)

Area of Science:

• Immunology
• Molecular Biology
• Oncology

Background:

• Interferon-gamma (IFN-gamma) is a lymphokine with demonstrated antitumoral activity.
• Its effects on malignant cells stem from direct growth inhibition and immunomodulatory actions.
• IFN-gamma exerts its functions by binding to high-affinity cell surface receptors, constitutively present across various cell lines.

Purpose of the Study:

• To investigate the role of IFN-gamma receptors in mediating the antitumoral effects of IFN-gamma.
• To understand the structural characteristics of the IFN-gamma receptor complex.
• To explore the implications of receptor heterogeneity on cellular response and clinical applications.

Main Methods:

• Analysis of existing data on IFN-gamma receptor structure and expression.
• Characterization of receptor-ligand interactions.
• Comparative assessment of receptor quantity across different tumor cell types.

Main Results:

• The IFN-gamma receptor is a heterodimeric molecule (128 kDa) composed of 53 kDa and 75 kDa subunits.
• Receptor expression is invariant in tumor cells, yet response to IFN-gamma varies.
• Cellular response magnitude correlates with the number of receptor-ligand interactions.
• Significant heterogeneity in receptor numbers (over 20-fold differences) exists among tumor cells.

Conclusions:

• Cellular response to IFN-gamma is primarily determined by post-receptor events.
• The quantity of IFN-gamma receptors significantly impacts the magnitude of cellular response.
• Understanding receptor heterogeneity is crucial for optimizing IFN-gamma dosage in clinical settings.